Figure 2
Trichimerism in cells derived from hematopoietic cells from peripheral blood, bone marrow, and lymph node. (A) Examples of marrow trichimerism in 3 of the dogs given marrow transplants from 2 DLA-identical donors determined at the weeks after HCT shown. (B) Chimerism analysis for dog G643, 34 weeks after HCT, of granulocytes and mononuclear cells from peripheral blood cells; CD45+ (leukocytes), CD34+ (progenitor stem cells), and DM5+ (myeloid cells) from bone marrow; CD3+ (T-cell antigen) and CD21 + (B-cell antigen) from lymph node cells. Cells were labeled with antibodies indicated above and sorted by FACS before determining chimerism.

Trichimerism in cells derived from hematopoietic cells from peripheral blood, bone marrow, and lymph node. (A) Examples of marrow trichimerism in 3 of the dogs given marrow transplants from 2 DLA-identical donors determined at the weeks after HCT shown. (B) Chimerism analysis for dog G643, 34 weeks after HCT, of granulocytes and mononuclear cells from peripheral blood cells; CD45+ (leukocytes), CD34+ (progenitor stem cells), and DM5+ (myeloid cells) from bone marrow; CD3+ (T-cell antigen) and CD21 + (B-cell antigen) from lymph node cells. Cells were labeled with antibodies indicated above and sorted by FACS before determining chimerism.

Close Modal

or Create an Account

Close Modal
Close Modal